TMX Newsfile Health News Releases

Cheelcare Announces a Non-Brokered Private Placement to Raise up to $1.5 Million

Thu, 11 Jun 2026 16:30:00 -0400

Markham, Ontario--(Newsfile Corp. - June 11, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, announces a non-brokered private placement for the issuance of up to 1,000,000 units of the Company (the "Units") at a price of $1.50 per Unit for aggregate gross proceeds of up to $1,500,000 (the "Offering"). Each Unit consists of one common share in the capital of the Company (a "Share") and one-half of one Common...

Edison Issues Report on SCHMID (SHMD)

Thu, 11 Jun 2026 11:43:00 -0400

London, United Kingdom--(Newsfile Corp. - June 11, 2026) - Edison issues report on SCHMID (NASDAQ: SHMD).SCHMID is a designer and manufacturer of equipment used in the electronics industry for printed circuit board (PCB) and advanced packaging manufacturing. Focused on the higher end of the sector where advances in packaging are driving demand for new processes and materials, SCHMID has developed cutting-edge tools and patented processes. After a couple of years of weaker demand, management...

Tersis Technologies and Pingkas Capital Sign MOU to Deploy Syngenic V3 Waste-to-Energy Platform in the Philippines

Thu, 11 Jun 2026 10:13:00 -0400

Brooksville, Florida--(Newsfile Corp. - June 11, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis"), a developer of advanced waste-to-energy and circular-economy technologies, today announced that it has signed a Memorandum of Understanding (MOU) with JL Equities Cap, LLC, doing business as Pingkas Capital ("Pingkas"), to jointly develop, finance, deploy, and operate waste-to-energy projects in the Republic of the Philippines using the Tersis Syngenic V3 technology platform.Big news for...

CBD of Denver Announces Strategic Exploration of Merger Candidates

Thu, 11 Jun 2026 09:00:00 -0400

Wallisellen, Switzerland--(Newsfile Corp. - June 11, 2026) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that its Board of Directors has authorized a strategic review of three merger candidates operating within the artificial intelligence (AI) industry. Management is identifying and evaluating their potential and how potentially CBDD will have benefit of it. The Company is specifically focused on businesses that are actively developing and deploying AI-powered tools designed to reduce...

Cosmo Welcomes the Launch of Winlevi(R) in Key European Markets by Its Partner Glenmark

Thu, 11 Jun 2026 01:19:00 -0400

Dublin, Ireland--(Newsfile Corp. - June 11, 2026) - Cosmo N.V. (SIX: COPN) (XETRA: C43) (“Cosmo”) is pleased to make known that its commercial partner Glenmark Specialty S.A (GSSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd., today announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18...

Psyched Wellness Provides Corporate Update

Wed, 10 Jun 2026 17:15:00 -0400

Toronto, Ontario--(Newsfile Corp. - June 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, announces that Jeff Stevens has stepped down from his position as Chief Executive Officer and resigned as a director of the Company, each effective May 31, 2026.Mr. Stevens has also resigned from all of...

Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada

Wed, 10 Jun 2026 09:15:00 -0400

Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/300817_screenshot_adia_med_inc_official_on_nevada.jpgThe move is more than cosmetic — it's a clear signal of where Adia is headed. Shifting from "Nutrition" to "Med" puts the spotlight on the...

Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch

Wed, 10 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., has officially launched a targeted market test and comprehensive product trial across the Commonwealth of The Bahamas. The pilot program is being executed in direct partnership with a premier mobile-first delivery application, digital logistics, and...

Custom Health Announces Closing of the Acquisition of InnovativeRx Operating Subsidiaries to Expand Integrated Medication Management Infrastructure Across North America

Wed, 10 Jun 2026 07:00:00 -0400

Strategic Acquisition: Custom Health announces the closing of the acquisition of substantially all of the operating assets of InnovativeRx US Holdings, Inc. ("InnovativeRx") to expand its integrated healthcare infrastructure across North America. InnovativeRx is an existing operational partner already utilizing Custom Health's proprietary AdhereNet® platform, enabling streamlined integration and workflow continuity.Financial information: The InnovativeRx acquisition is expected to be immediately...

Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada

Tue, 09 Jun 2026 17:30:00 -0400

UM171 Cell Therapy is conditionally approved in Europe as Zemcelpro® (dorocubicel)Securing Canadian rights to a proprietary advanced clinical-stage product candidate developed in Canada adds to Medexus's medium-term product pipeline and helps build a North American allo-HSCT franchiseToronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 9, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the company has secured exclusive Canadian rights to...